PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

Clinical trial NCT06157151 · RECRUITING

Trial details

NCT number: NCT06157151
Sponsor: Precigen, Inc
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer HPV-Related Carcinoma HPV-Related Malignancy Recurrent Cervical Carcinoma Metastatic Cervical Cancer

Start date: 2025-11-11
Primary completion: 2026-11-11
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.